Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.5465
-0.0035 (-0.64%)
Apr 2, 2026, 4:00 PM EDT - Market closed

MTNB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--1.13.190.03
Revenue Growth (YoY)
---65.62%9560.61%-79.16%
Gross Profit
--1.13.190.03
Selling, General & Admin
6.888.7310.3711.110.19
Research & Development
0.0911.4314.4916.6814.58
Other Operating Expenses
-4.43---
Total Operating Expenses
6.9624.5924.8627.7824.77
Operating Income
-6.96-24.59-23.77-24.59-24.74
Total Non-Operating Income (Expense)
-3.390.260.823.591.45
Pretax Income
-10.35-24.33-22.94-21-23.28
Provision for Income Taxes
--0.08---
Net Income
-10.96-24.25-22.94-21-23.68
Net Income Attributable to Preferred Dividends
0.62---0.4
Net Income to Common
-10.96-24.25-22.94-21-23.68
Shares Outstanding (Basic)
55444
Shares Outstanding (Diluted)
55444
Shares Change (YoY)
12.50%11.98%0.21%3.16%6.75%
EPS (Basic)
-2.00-4.98-5.28-5.00-5.50
EPS (Diluted)
-2.00-4.98-5.28-5.00-5.50
Shares Outstanding
6.415.094.354.354.33
Free Cash Flow
-7.01-15.89-15.5-20.05-15.48
Free Cash Flow Per Share
-1.28-3.26-3.57-4.62-3.68
Gross Margin
--100.00%100.00%100.00%
Operating Margin
---2168.43%-771.33%-74954.55%
Profit Margin
---2093.25%-658.63%-70554.55%
FCF Margin
---1413.87%-628.86%-46918.18%
EBITDA
-6.5-23.62-22.83-23.69-23.95
EBITDA Margin
---2082.57%-743.16%-72587.88%
EBIT
-6.96-24.59-23.77-24.59-24.74
EBIT Margin
---2168.43%-771.33%-74954.55%
Effective Tax Rate
0.00%0.33%0.00%0.00%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q